Approval for immulite afp for use with the immulite analyzer  and immulite 2000 afp for use with the immulite 2000 analyzer.  These devices are indicated for in vitro diagnostic use for the quantitative measurement of alpha-fetoprotein (afp) in either of two contexts:  a)  serial measurements in human serum to aid in the management of patients with nonseminomatous testicular cancer: or  b) measurement in maternal serum and amniotic fluid during gestational weeks 15 through 20 - used in conjunction with ultrasonography or amniography - to aid in detection of fetal open neural tube defects.